Clinical Trial Update: Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403 [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting long-term efficacy and safety of repeated courses of ofatumumab in rheumatoid arthritis patients previously treated with or witho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Arzerra (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: TERMINATED | Results posted: 2012-04-18